NCT06363123 2024-04-15Plasma Metabolic Biomarkers for Multi-Cancer DiagnosisBeijing Friendship HospitalUnknown2,700 enrolled
NCT05311618 2024-04-01Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid TumorsNGM Biopharmaceuticals, IncPhase 1 Unknown71 enrolled
NCT04801095 2022-09-16A Phase I Study of WM-S1-030 in Patients With Advanced Solid TumorsWellmarker BioPhase 1 Unknown100 enrolled